Brian Bares’s Bares Capital Management boosted his stake in Female Health Company (FHCO) to 10.07% in early June. Bares had 2,291,861 shares of Female Health Company (FHCO) in its portfolio at the end of March. The fund currently holds 2.8 Million shares of the company. The stock closed at 4.93 on Friday, July 8th.
Brian Bares’s Bares Capital Management is the largest shareholder in FHCO with a $14 Million position. George Soros’s Soros Fund Management sold its entire 1.4 Million share stake in FHCO at the end of March.
Austin-based Bares Capital Investment was established in 2000. Brian Bares is a bottom-up investor focusing on small and micro-cap companies. He runs a long-only concentrated portfolio of inefficiently priced stocks and he usually has a very low turnover in his portfolio. Bares Capital’s micro-cap strategy had 53% in gross returns in 2010. He published a book titled “The Small Cap Advantage: How Top Endowments and Foundations Turn Small Stocks into Big Returns”. Brian Bares graduated from the University of Nebraska with a degree in Mathematics.
Google Finance states that “FCHO manufactures markets and sells the FC2 female condom. FC2 is the only available product under a woman’s control and approved by the United States Food and Drug Administration (FDA) that provides dual protection against unintended pregnancy and sexually transmitted infections (STIs), including Human Immunodeficiency Virus/ Acquired Immunodeficiency Syndrome (HIV/AIDS). In October 2009, the Company transition from its first generation product, FC1, to its second generation product, FC2, and production of FC1 ceased. Although it retains its ownership of certain world-wide rights to FC1. FC2, approved by FDA as a Class III medical device became available in the United States in August 2009. From introduction through September 30, 2010, 80 million FC2 female condoms have been distributed in 114 countries. The last shipments of FC1 were produced and sold in October 2009.”